Valentina Milanova is the Founder and CEO of Daye, a pioneering gynaecological health company dedicated to closing the gender health gap through innovative products and research. Born in Bulgaria, Valentina pursued her education in the UK, earning degrees in Business, Economics, and Law from the University of Buckingham, followed by a Master’s in International and Trade Law. She further specialised in Food and Drug Law at Harvard and is currently completing a Master of Public Health at Imperial College London.
Valentina’s work is rooted in addressing unmet needs in women’s health. Inspired by her personal experiences with menstrual pain, she founded Daye in 2018 to revolutionize period care and gynaecological health screening. Under her leadership, Daye developed diagnostic tampons for at-home STI and HPV screening. Her innovations have reached over 100,000 patients in the UK and contributed to advancing research on vaginal health. Valentina has also published scientific work in The Journal of Human Reproduction, The Journal of Endometriosis and Uterine Disorders, and The Journal of Microbiology.
Beyond her entrepreneurial achievements, Valentina is committed to sustainability, having led Daye to achieve B-Corp certification and carbon neutrality. She continues to drive innovation in gynaecological health while mentoring early-stage femtech startups and advocating for gender equality in healthcare.